[Use of the CHADS2 score as a predictor of the risk of mortality in hypertensive patients. The FAPRES study].
作者信息
Castilla Elena, Morillas Pedro, Gómez Manuel, Ahumada Miguel, Monteagudo Marta, Fácila Lorenzo, Pallares Vicente
机构信息
Servicio de Cardiología, Hospital General Universitario de Elche, Elche, Alicante, España.
Servicio de Cardiología, Hospital General Universitario de Elche, Elche, Alicante, España.
出版信息
Med Clin (Barc). 2016 Jun 3;146(11):478-83. doi: 10.1016/j.medcli.2016.03.015. Epub 2016 Apr 30.
FOUNDATIONS AND AIM
The aim of this study is to analyze the CHADS2 score as a marker of the risk of mortality in hypertensive patients, with and without the presence of atrial fibrillation.
METHODS
We included 1,003 hypertensive patients≥65 years. Risk factors, and CHADS2 score were recorded among other factors, as well as clinical follow-up of number and type of deaths.
RESULTS
Mean age was 72.8±5.8 years, and 47.5% were men. During follow-up there were 41 deaths, 20 were of cardiovascular origin. Patients with higher CHADS2 had a higher mortality: 1.5% CHADS2=1; 4.7% in CHADS2=2; 9.1% in CHADS2=3, and 7.8% in CHADS2≥4.
CONCLUSIONS
The CHADS2 score can be a clinical instrument of easy application to identify hypertensive patients with a high risk of mortality.
Zotero 插件